The Trillion-Dollar Conspiracy (19 page)

Rife’s troubles turned more serious. His lab was ransacked on several occasions, but no suspect was ever caught. He was also harassed by health officials. Baseless and costly lawsuits were brought against him resulting in his bankruptcy. The suits, some filed by persons with connections to pharmaceutical corporations, ultimately failed. The USC’s Special Research Committee was disbanded, Rife was marginalized, and his device today is available only as a costly research instrument employed by a few doctors and private citizens. Rife died a broken man in 1971.

Although Rife’s work has been confirmed by scientists and researchers outside the United States, the conventional medical community still ignores the benefits of this technology and continues to prosecute those who do. Those Americans who have confirmed or endorsed various areas of Rife’s work include Dr. Edward C. Rosenow Sr., former chief of bacteriology at the Mayo Clinic; Dr. Arthur I. Kendall of Northwestern Medical School; Dr. George Dock of the Los Angeles County Medical Association library; Dr. Alvin Foord, professor of pathology at the University of Southern California; Rufus Klein-Schmidt, president of USC; Dr. Milbank Johnson, director of the Southern California AMA; Whalen Morrison, chief surgeon for the Santa Fe Railway; Dr. George Fischer of Children’s Hospital, New York; Karl Meyer, with the Hooper Foundation; and many others.

Barry Lynes, a California investigative reporter, learned of the Rife story through John Crane, who had worked at Rife’s side from 1950 until Rife’s death in 1971. Initially skeptical of the claims of the healing benefits of Rife technology, after studying the documentation held by Crane, Lynes became outraged by the injustices that had wrecked Rife’s life’s work. Lynes’s 1987 book on Rife and his work, entitled
The Cancer Cure That Worked! Fifty Years of Suppression,
became an underground favorite and sparked renewed interest in Rife’s work. Starting in 1995, San Diego manufacturer James Folsom marketed and distributed Rife-type devices when he took over the Royal Rife Research Society. He claimed to have hundreds of testimonials that his devices improved physical symptoms, and in many cases led to remission in cancer. According to Folsom, he had no dissatisfied customers.

Folsom was raided by the FDA in 2003 during Operation Cure All, a campaign that targeted various companies in the alternative-health market. Although Folsom’s equipment was confiscated, Folsom heard no more about it for years. But then in October 2007, just days before his vulnerability would have ended under a statute of limitations, Folsom was arrested and charged with several felonies, including selling a class III medical instrument without a license. Folsom argued he did not need a license because his equipment was a class I biofeedback device. These devices were exempt and had been used for more than seventy years with no known harm or side effects. Regardless, the FDA claimed these biofeedback devices were under its jurisdiction over medical devices under a 1976 law. That law allowed for the prosecution of selling high-voltage medical devices. However, it should be noted that Folsom’s machine at that time could be powered by a nine-volt battery.

Despite being offered a plea bargain that would allow him to plead guilty to a misdemeanor and make him pay a $250 fine and suffer one year of unsupervised probation, Folsom decided to go to trial.

According to U.S. Attorney Karen Hewitt, Folsom’s business generated more than $8 million in revenue over its years in operation. Assistant U.S. Attorney Melanie Pierson said the case was the largest involving illegal medical devices that she had seen in twenty years working as a prosecutor in San Diego County.

The trial was held in U.S. District Court, where no discussion of the effectiveness of the Rife’s technology was allowed. Originally, Folsom wanted to produce stacks of testimonials from satisfied customers but Melanie Pierson objected. Folsom then tried to assert that for more than seventy years, no harmful effects had been documented from the devices. This too was not allowed. Folsom then tried to argue that none of his customers had been dissatisfied, but to no effect. Aside from prosecutors and government officials, the only witnesses at the trial were twenty-four of Folsom’s friends and fellow device distributors. They unanimously testified to Folsom’s good character and clean business practices. Incredibly, the prosecution used this testimony against Folsom, claiming that, in fact, Folsom was such a brilliant fraud that even his peers and customers weren’t aware they’d been defrauded. Prosecutors claimed Folsom used the false name “Jim Anderson” to avoid being caught by the FDA, and that he gave buyers the false impression that the FDA had approved the devices for “investigational purposes.” Folsom admitted he had used the name as a salesman at a different company but had used his real name on all official and government correspondence.

In February 2009, a U.S. federal jury in San Diego convicted Folsom of twenty-six felony counts for selling Rife devices under the name of “Nature-tronics,” “AstroPulse,” “Biosolutions,” “Energy Wellness,” and “Global Wellness.” Folsom, sixty-eight, faced more than 140 years in prison, literally a life sentence at his age, and $500,000 in fines. He is being held in the federal government’s Western Region Detention Facility in San Diego, now managed by the private firm GEO Group, Inc.

A few weeks after Folsom’s trial and conviction, the FDA issued a news release announcing that manufacturers of twenty-five types of medical devices marketed prior to 1976 must submit safety and effectiveness information to the agency so that it may evaluate the risk level for each device type. Supporters of Folsom said the FDA’s decision to scrutinize such preexisting technology was most likely the result of his trial.

One Folsom supporter stated, “Jim stood on his principles for his innocence and to clear the Rife name. It was an impossible task. Jim was up against an endless supply of money through the FDA and an unjust system. Research has found since Jim’s conviction that our judicial system is more of a money machine than Big Pharma & the Medical Industrial Complex.”

Observers saw Folsom’s conviction as a blow against those supporting Rife technology. They also predicted that those interested in the technology would have to go to foreign websites such as http://www.rife.de/, a site in Germany where the sales and use of Rife-type devices are legal.

With the FDA seeking to require prescriptions for everyday vitamins and suppressing potentially useful medical technologies like Rife’s, not to mention the new government-controlled national health-care plan, it would appear as though there is a conscious effort to prevent the public from acquiring healthful alternatives to chemical drugs.

But why would the government harm us with untested vaccines and the suppression of potentially healthful therapies? Wouldn’t such actions also adversely affect the health of the global elite? Some researchers believe the answer may be that the inner-core globalists already utilize such technology or something even more advanced. Is it possible they can cure themselves of the same illnesses they allow to be inflicted on others? The globalist elites may not be worried that their eugenics plans will touch their families. They may believe they can protect their own DNA with race-specific pathogens. If they should contact some dire affliction, might they easily eliminate it with just a few short hours of frequency technology or advanced antidotes for immunization—therapies cloaked from the general population.

The possibility of holding such publicly denied therapies that might end disease and halt or regress the aging process would prove a most effective enticement in the recruitment of minions to aid in the advancement of their globalist agendas.

DRUGGING THE POPULATION

BIG PHARM

D
RUGS ARE BIG BUSINESS
. Only five biopharmaceutical companies—Novartis, GlaxoSmithKline, MedImmune, the Australian firm CSL, and Sanofi-Pasteur—have been awarded massive contracts by the U.S. Department of Health and Human Services (HHS) to develop and produce more than 195 million doses of swine flu vaccine. This is in addition to the seasonal flu vaccine.

According to Dr. Joseph Mercola, an osteopathic physician and author of sixteen books on health and alternative medicine, including two
New York Times
bestsellers, “CSL has contracts to supply $180 million worth of bulk antigen to the U.S. MedImmune will supply 40 million doses of its live attenuated nasal spray swine flu vaccine for more than $450 million. And Sanofi-Pasteur is providing more than 100 million doses of monovalent swine flu vaccine, a $690 million order.”

About half of the world’s largest pharmaceutical corporations are not American, but rather European. Among the top ten pharmaceutical companies are the American companies Pfizer, Merck, Johnson & Johnson, Bristol-Myers Squibb, and Wyeth (formerly American Home Products). The rest of the top pharmaceutical companies are the British companies GlaxoSmithKline and AstraZeneca; the Swiss companies Novartis and Roche; and the French company Aventis (which in 2004 merged with another French company, Sanafi Synthelabo, putting it in third place). These corporations essentially function alike, but their drug prices in America are much higher than in other nations’ markets. For example, a bottle of one thousand aspirin costs less in Mexico than a bottle of five hundred across the border in the United States and, obviously, no company will sell a product without making a profit.

To give some indication of the money involved in the modern drug business, the legal pharmaceutical market totaled $712 billion globally in 2007, of which about $80 billion was for psychiatric drugs. According to several authorities, including Harvard psychiatrist Dr. Peter R. Breggin; Bruce Wiseman, national president of the Citizens Commission on Human Rights; geneticist Dr. Thomas Roeder; Dr. Hyla Cass, a former assistant clinical professor of psychiatry at UCLA School of Medicine; and David Healey and David B. Menkes, both of the North Wales Department of Psychological Medicine, psychiatric drugs may be the culprit behind many homicides, suicides, and school shootings.

Even worse, the $80 billion doesn’t even include the illegal drug market. A former editor in chief of the
New England Journal of Medicine,
Dr. Marcia Angell, wrote in the
New York Review of Books,
“The combined profits for the ten drug companies in the Fortune 500 ($35.9 billion) were more than the profits for all the other 490 businesses put together ($33.7 billion). Over the past two decades the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs. Now primarily a marketing machine to sell drugs of dubious benefit, this industry uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centers, and the medical profession itself.”

In her 2004 book
The Truth About the Drug Companies: How They Deceive Us and What to Do About It,
Dr. Angell argues that the current power of the pharmaceutical industry can be directly traced to the industry’s phenomenal growth during the Reagan years, with George H. W. Bush and his globalist supporters in command following Reagan’s wounding during an assassination attempt in March 1981.

“The watershed year was 1980,” she noted. “Before then, it was a good business, but afterward, it was a stupendous one. From 1960 to 1980, prescription drug sales were fairly static as a percent of US gross domestic product, but from 1980 to 2000, they tripled. They now stand at more than $200 billion a year. Of the many events that contributed to the industry’s great and good fortune, none had to do with the quality of the drugs the companies were selling.”

The success of Big Pharm has more to do with marketing than with the effectiveness of its drugs. Dr. Michael Wilkes, professor of medicine and vice dean for medical education at the University of California, Davis, joined other critics in describing a recent phenomenon called “disease-mongering,” an activity in which large drug corporations attempt to convince healthy people they are sick and need drugs in order to boost sales.

“Most pharmaceutical companies devote huge amounts of money to prevent, control and cure diseases,” he added. “When their profits don’t match corporate expectations, they ‘invent’ new diseases to be cured by existing drugs.”

“Countless examples of disease-mongering are driven by the pharmaceutical industry’s drive to sell drugs,” wrote Dr. Wilkes. “Conditions such as female sexual dysfunction syndrome, premenstrual dysphoric disorder, toenail fungus, baldness and social anxiety disorder (a.k.a. shyness) are a few places where the medical community has stepped in, thereby turning normal or mild conditions into diseases for which medication is the treatment.”

Ironically, though Big Pharm invents new diseases, they rarely invent a new drug. Surprisingly, most new and important drugs brought to market in recent years were based on taxpayer-funded research at universities, small biotechnology companies, or the National Institutes of Health (NIH). In fact, most supposedly “new” drugs are merely a variation of older drugs.

“If I’m a manufacturer and I can change one molecule and get another twenty years of patent rights, and convince physicians to prescribe and consumers to demand the next form of Prilosec, or weekly Prozac instead of daily Prozac, just as my patent expires, then why would I be spending money on a lot less certain endeavor, which is looking for brand-new drugs?” asked Dr. Sharon Levine, associate executive director of the Kaiser Permanente Medical Group.